• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大疱性类天疱疮发病机制的研究进展:补体非依赖机制的作用。

Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.

机构信息

Division of Dermatology, Rush University Medical Center, Chicago, IL, United States.

Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Front Immunol. 2022 Jul 7;13:912876. doi: 10.3389/fimmu.2022.912876. eCollection 2022.

DOI:10.3389/fimmu.2022.912876
PMID:35874745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9300999/
Abstract

Bullous pemphigoid is an autoimmune blistering disease caused by autoantibodies targeting BP180 and BP230. While deposits of IgG and/or complement along the epidermal basement membrane are typically seen suggesting complement -mediated pathogenesis, several recent lines of evidence point towards complement-independent pathways contributing to tissue damage and subepidermal blister formation. Notable pathways include macropinocytosis of IgG-BP180 complexes resulting in depletion of cellular BP180, direct induction of pro-inflammatory cytokines from keratinocytes, as well as IgE autoantibody- and eosinophil-mediated effects. We review these mechanisms which open new perspectives on novel targeted treatment modalities.

摘要

大疱性类天疱疮是一种自身免疫性水疱病,由针对 BP180 和 BP230 的自身抗体引起。虽然通常可见 IgG 和/或补体沿着表皮基底膜沉积,提示补体介导的发病机制,但最近有几条证据表明补体非依赖性途径有助于组织损伤和表皮下水疱形成。值得注意的途径包括 IgG-BP180 复合物的巨胞饮作用导致细胞 BP180 的耗竭,角质形成细胞直接诱导促炎细胞因子,以及 IgE 自身抗体和嗜酸性粒细胞介导的作用。我们综述了这些机制,为新的靶向治疗方式开辟了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/9300999/1ae4e24f778b/fimmu-13-912876-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/9300999/53b524fb8651/fimmu-13-912876-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/9300999/1ae4e24f778b/fimmu-13-912876-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/9300999/53b524fb8651/fimmu-13-912876-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a3/9300999/1ae4e24f778b/fimmu-13-912876-g002.jpg

相似文献

1
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.大疱性类天疱疮发病机制的研究进展:补体非依赖机制的作用。
Front Immunol. 2022 Jul 7;13:912876. doi: 10.3389/fimmu.2022.912876. eCollection 2022.
2
Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.奥马珠单抗作为附加疗法治疗一线治疗耐药性黏膜类天疱疮和大疱性类天疱疮的快速疾病控制:13 例患者的病例系列。
Front Immunol. 2022 Apr 20;13:874108. doi: 10.3389/fimmu.2022.874108. eCollection 2022.
3
Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.大疱性类天疱疮患者血清中抗BP180和抗BP230自身抗体的水平。
J Dermatol Sci. 2008 Feb;49(2):153-61. doi: 10.1016/j.jdermsci.2007.08.008. Epub 2007 Oct 24.
4
Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.大疱性类天疱疮:补体的作用和在透明层内水疱形成的机制。
Exp Dermatol. 2013 Jun;22(6):381-5. doi: 10.1111/exd.12146. Epub 2013 May 7.
5
Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.BP230 型大疱性类天疱疮中 IgG 亚类的特点和补体沉积。
J Eur Acad Dermatol Venereol. 2019 Mar;33(3):595-600. doi: 10.1111/jdv.15325. Epub 2018 Nov 28.
6
Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.大疱性类天疱疮(BP)患者选择性 IgG 自身抗体针对 BP230:罕见但有价值队列的回顾性研究,对 BP 发病机制的理解有影响。
J Dermatol Sci. 2022 Feb;105(2):72-79. doi: 10.1016/j.jdermsci.2021.11.011. Epub 2021 Dec 1.
7
Eosinophils in bullous pemphigoid.大疱性类天疱疮中的嗜酸性粒细胞。
Panminerva Med. 2021 Sep;63(3):368-378. doi: 10.23736/S0031-0808.20.03997-X. Epub 2020 Jun 12.
8
Autoimmunity in bullous pemphigoid.大疱性类天疱疮中的自身免疫。
G Ital Dermatol Venereol. 2009 Aug;144(4):411-21.
9
IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.针对BP230免疫显性C末端表位的IgG抗体不会在小鼠中诱发皮肤水疱。
Hum Immunol. 2014 Apr;75(4):354-63. doi: 10.1016/j.humimm.2014.01.005. Epub 2014 Jan 24.
10
IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.大疱性类天疱疮、瘢痕性类天疱疮及线状 IgA 大疱性皮病患者中针对 BP180 胞外结构域的 IgG、IgA 和 IgE 自身抗体
Br J Dermatol. 2000 Aug;143(2):349-55. doi: 10.1046/j.1365-2133.2000.03661.x.

引用本文的文献

1
IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes.大疱性类天疱疮中的IgG自身抗体在角质形成细胞中诱导致病性的依赖MyD88的促炎反应。
Nat Commun. 2025 Aug 6;16(1):7254. doi: 10.1038/s41467-025-62495-2.
2
Recent advances in the genetics and innate immune cells of bullous pemphigoid.大疱性类天疱疮的遗传学和固有免疫细胞的最新进展。
Front Immunol. 2025 Jun 18;16:1530407. doi: 10.3389/fimmu.2025.1530407. eCollection 2025.
3
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid.

本文引用的文献

1
Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.评价 Nomacopan 治疗大疱性类天疱疮:一项 2a 期非随机对照试验。
JAMA Dermatol. 2022 Jun 1;158(6):641-649. doi: 10.1001/jamadermatol.2022.1156.
2
Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes.抗层粘连蛋白 332 自身抗体的亚单位特异性反应揭示了角质细胞的直接炎症机制。
Front Immunol. 2021 Nov 25;12:775412. doi: 10.3389/fimmu.2021.775412. eCollection 2021.
3
BP180/Collagen XVII: A Molecular View.
JAK-STAT信号通路、I/II型细胞因子与自身免疫性大疱性疾病的新潜在治疗策略:寻常型天疱疮和大疱性类天疱疮的最新进展
Front Immunol. 2025 Apr 8;16:1563286. doi: 10.3389/fimmu.2025.1563286. eCollection 2025.
4
The role of C4d expression in the diagnosis of bullous pemphigoid: a clinical and histopathological study.C4d表达在大疱性类天疱疮诊断中的作用:一项临床与组织病理学研究
Arch Dermatol Res. 2025 Mar 17;317(1):569. doi: 10.1007/s00403-025-04031-2.
5
Associated factors related to production of autoantibodies and dermo-epidermal separation in bullous pemphigoid.大疱性类天疱疮中与自身抗体产生及皮肤表皮分离相关的因素。
Arch Dermatol Res. 2025 Jan 24;317(1):303. doi: 10.1007/s00403-024-03760-0.
6
Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid.度普利尤单抗、皮质类固醇及其联合用药治疗大疱性类天疱疮
An Bras Dermatol. 2025 Mar-Apr;100(2):243-252. doi: 10.1016/j.abd.2024.04.012. Epub 2024 Dec 17.
7
Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-Analysis.大疱性类天疱疮的严重程度和抗 BP180 与 BP230 抗体水平:系统评价和荟萃分析。
JAMA Dermatol. 2024 Nov 1;160(11):1192-1200. doi: 10.1001/jamadermatol.2024.3425.
8
Impact of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review.严重急性呼吸综合征冠状病毒2刺突蛋白对固有免疫系统的影响:综述
Cureus. 2024 Mar 26;16(3):e57008. doi: 10.7759/cureus.57008. eCollection 2024 Mar.
9
Anti-Idiotypic mRNA Vaccine to Treat Autoimmune Disorders.用于治疗自身免疫性疾病的抗独特型mRNA疫苗。
Vaccines (Basel). 2023 Dec 21;12(1):9. doi: 10.3390/vaccines12010009.
10
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.从药物相关性大疱性表皮松解症的分子见解到临床观点。
Int J Mol Sci. 2023 Nov 26;24(23):16786. doi: 10.3390/ijms242316786.
BP180/Collagen XVII:分子视角。
Int J Mol Sci. 2021 Nov 12;22(22):12233. doi: 10.3390/ijms222212233.
4
Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.度普利尤单抗治疗中重度大疱性类天疱疮的疗效和安全性。
Front Immunol. 2021 Oct 14;12:738907. doi: 10.3389/fimmu.2021.738907. eCollection 2021.
5
A Scoping Review of the Role of Metalloproteinases in the Pathogenesis of Autoimmune Pemphigus and Pemphigoid.自身免疫性天疱疮和类天疱疮发病机制中金属蛋白酶作用的范围综述。
Biomolecules. 2021 Oct 13;11(10):1506. doi: 10.3390/biom11101506.
6
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.欧洲皮肤病学与性病学会发起的黏膜类天疱疮诊断与治疗指南(S3)——第二部分。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):1926-1948. doi: 10.1111/jdv.17395. Epub 2021 Jul 26.
7
Characterizing the proteome of bullous pemphigoid blister fluid utilizing tandem mass tag labeling coupled with LC-MS/MS.利用串联质量标签标记结合 LC-MS/MS 技术分析大疱性类天疱疮疱液的蛋白质组学特征。
Arch Dermatol Res. 2022 Nov;314(9):921-928. doi: 10.1007/s00403-021-02253-8. Epub 2021 Jun 21.
8
Neutrophil extracellular traps contribute to immune dysregulation in bullous pemphigoid via inducing B-cell differentiation and antibody production.中性粒细胞胞外诱捕网通过诱导 B 细胞分化和抗体产生导致大疱性类天疱疮免疫失调。
FASEB J. 2021 Jul;35(7):e21746. doi: 10.1096/fj.202100145R.
9
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.病例报告:奥马珠单抗和度普利尤单抗联合治疗难治性大疱性类天疱疮。
Front Immunol. 2021 Jan 29;11:611549. doi: 10.3389/fimmu.2020.611549. eCollection 2020.
10
Immunoglobulin M pemphigoid.免疫球蛋白 M 型天疱疮。
J Am Acad Dermatol. 2021 Dec;85(6):1486-1492. doi: 10.1016/j.jaad.2021.01.017. Epub 2021 Jan 13.